The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
FULCRUM THERAPEUTICS INC | COM | 359616109 | 1,273,207 | 205,356 | SH | SOLE | 0 | 0 | 0 | ||
REVOLUTION MEDICINES INC | COM | 76155X100 | 13,125,193 | 338,191 | SH | SOLE | 0 | 0 | 0 | ||
PLIANT THERAPEUTICS INC | COM | 729139105 | 3,103,418 | 288,690 | SH | SOLE | 0 | 0 | 0 | ||
TANGO THERAPEUTICS INC | COM | 87583X109 | 3,038,967 | 354,192 | SH | SOLE | 0 | 0 | 0 |